- Trials with a EudraCT protocol (37)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
37 result(s) found for: Infectious tolerance.
Displaying page 1 of 2.
EudraCT Number: 2005-000567-25 | Sponsor Protocol Number: 100063 | Start Date*: 2005-08-10 | |||||||||||
Sponsor Name:NUMICO RESEARCH BV | |||||||||||||
Full Title: Tolerance and immunological response in HIV seropositive individuals after NR100063 supplementation | |||||||||||||
Medical condition: HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005308-15 | Sponsor Protocol Number: n/a | Start Date*: 2007-03-15 |
Sponsor Name:University Heidelberg, Department of General Surgery | ||
Full Title: Pilot study of the safety and tolerance of preoperative melatonin application in patients undergoing major liver resection. | ||
Medical condition: postoperative infectious complications ICD classification code : T 81.4 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001635-27 | Sponsor Protocol Number: AB20001 | Start Date*: 2020-05-04 | |||||||||||
Sponsor Name:AB Science | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Masitinib combined with Isoquercetin, and Best Supportive Care in Hospitalized Patients ... | |||||||||||||
Medical condition: Hospitalized Moderate and Severe COVID-19 Patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000366-18 | Sponsor Protocol Number: 2020/0420/HP | Start Date*: 2022-08-18 | |||||||||||
Sponsor Name:CHU de ROUEN | |||||||||||||
Full Title: Efficacy and Tolerance of Baricitinib, a JAK inhibitor, in the treatment of refractory non-infectious uveitis | |||||||||||||
Medical condition: Active non-anterior non-infectious uveitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001614-94 | Sponsor Protocol Number: 15-PP-03 | Start Date*: 2015-07-03 | |||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Nice | |||||||||||||
Full Title: Hepatoprotective role of SMOFlipid® used in short-term parenteral nutrition in an Onco-Hematology Pediatric Population, pilot study | |||||||||||||
Medical condition: parenteral nutrition in an Onco-Hematology Pediatric Population | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000755-13 | Sponsor Protocol Number: DACLEAN | Start Date*: 2020-03-31 | |||||||||||
Sponsor Name:CHU de Poitiers | |||||||||||||
Full Title: ESTIMATION OF THE INCIDENCE OF COLONIZATION OF PERIPHERAL VENOUS CATHETERS AFTER SKIN DISINFECTION WITH 0.5% SODIUM HYPOCHLORITE, PRECEDED OR NOT BY AN APPLICATION OF 70% ETHANOL: PILOT, MONOCENTRI... | |||||||||||||
Medical condition: Bacterial colonization of peripheral venous catheters | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003456-20 | Sponsor Protocol Number: ITN084AD | Start Date*: 2020-02-17 | |||||||||||
Sponsor Name:Division of Allergy, Immunology, and Transplantation; National Institute of Allergy and Infectious Disease | |||||||||||||
Full Title: Grass Pollen Sublingual Tablet Immunotherapy plus Dupilumab for Induction of Tolerance in Adults with Moderate to Severe Seasonal Allergic Rhinitis. | |||||||||||||
Medical condition: Moderate to Severe Seasonal Allergic Rhinitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000105-65 | Sponsor Protocol Number: 1 | Start Date*: 2006-08-30 |
Sponsor Name:Medical University of Vienna, Department of Internal Med. I, Division of Infectious Diseases | ||
Full Title: Comparative study of the efficacy and tolerance of intravenously administered azithromycin (1.5 g) given either as a single dose or over a 3 day period in patients with community-acquired pneumonia | ||
Medical condition: community aquired pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023529-39 | Sponsor Protocol Number: RHM CHI 0548 | Start Date*: 2011-02-18 |
Sponsor Name:Southampton University Hopsitals NHS Trust | ||
Full Title: Reducing antibiotic tolerance using low dose nitric oxide in cystic fibrosis – a phase 2 pilot study | ||
Medical condition: Cystic Fibrosis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-000673-24 | Sponsor Protocol Number: PHRC_N_2018_BAY | Start Date*: 2021-04-15 |
Sponsor Name:CHU de Clermont-Ferrand | ||
Full Title: Faecal microbiota transplantation for prevention of graft-versus-host sisease after allogeneic stem cell transplantation for haematological malignancies | ||
Medical condition: Patient who underwent Allogeneic hematopoietic stem cell transplantation (allo-HSCT) for various haematological malignancies. Faecal microbiota transplantation (FMT) will be assessed to prevent al... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000770-36 | Sponsor Protocol Number: 2009-18 | Start Date*: 2013-05-14 |
Sponsor Name:Centre Hospitalier Régional et Universitaire de Lille | ||
Full Title: | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001227-13 | Sponsor Protocol Number: SOPAZITHRO | Start Date*: 2022-02-22 | ||||||||||||||||
Sponsor Name:Centre hospitalier intercommunal de Créteil | ||||||||||||||||||
Full Title: Evaluation of the Efficacy of 3-month Continuous Extended Treatment With Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults: a Multicentre Randomised Controlled Trial | ||||||||||||||||||
Medical condition: Patients with Purulent Oedematous Sinusitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002128-32 | Sponsor Protocol Number: 200504 | Start Date*: 2006-04-13 |
Sponsor Name:Abteilung für Anaesthesiologie und Intensivmedizin | ||
Full Title: Serum concentrations and concentrations in epithelial lining fluid of antibiotics under continious infusion | ||
Medical condition: The CT will be carried out on an intensive care unit, including critical ill patients with severe infectious disease needing treatment with one or more antibiotics. These antibiotics are all admin... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004804-77 | Sponsor Protocol Number: 1262_OPBG_2018 | Start Date*: 2018-07-10 |
Sponsor Name:BAMBINO GESU' CHILDREN'S HOSPITAL | ||
Full Title: A prospective study to assess safety and efficacy of the use of bone-marrow derived MESenchymal stromal cells as immunomodulatory therapy for children and young adults with severe and difficult-to-... | ||
Medical condition: severe multi-relapsing or steroid-dependent INS. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004645-15 | Sponsor Protocol Number: P03579 | Start Date*: 2008-03-14 | ||||||||||||||||
Sponsor Name:Schering Plough Research Institute | ||||||||||||||||||
Full Title: Phase 1B Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children With Neutropenia | ||||||||||||||||||
Medical condition: treatment and prophylaxis of invasive fungal infections; oropharyngeal candidiasis (OPC) and refractory OPC | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) DE (Prematurely Ended) NL (Prematurely Ended) GR (Prematurely Ended) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000826-36 | Sponsor Protocol Number: P160905J | Start Date*: 2018-05-17 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Efficacy and safety of immunoglobulin associated with rituximab versus rituximab alone in Childhood-Onset steroid-dependent nephrotic syndrome | |||||||||||||
Medical condition: Childhood-Onset steroid-dependent nephrotic syndrome | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001138-10 | Sponsor Protocol Number: F-FR-00250-105 | Start Date*: 2016-01-06 | |||||||||||
Sponsor Name:Ipsen Pharma SAS | |||||||||||||
Full Title: Efficacy of diosmectite (Smecta®) in the symptomatic treatment of acute diarrhoea in adults. A multicentre, randomised, double-blind, placebo-controlled, parallel groups study | |||||||||||||
Medical condition: Acute diarrhoea in adult | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) CZ (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001379-18 | Sponsor Protocol Number: QEL-001-CLN-01 | Start Date*: 2023-07-07 | |||||||||||
Sponsor Name:Quell Therapeutics Limited | |||||||||||||
Full Title: A single-arm, open-label, multi-centre, phase I/II study evaluating the safety and clinical activity of QEL-001, an autologous CAR T regulatory cell treatment targeting HLA-A2, in HLA-A2/ A28neg pa... | |||||||||||||
Medical condition: Prevention of liver transplant rejection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002001-30 | Sponsor Protocol Number: IMUP | Start Date*: 2011-12-09 |
Sponsor Name:INFECTOPHARM Arzneimittel und Consilium GmbH | ||
Full Title: Multicenter, prospective, double-blind, two-armed phase III study for efficacy and safety of the topic impetigo therapy of two 2 % mupirocin ointments | ||
Medical condition: Impetigo | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-000442-21 | Sponsor Protocol Number: RC17_0029 | Start Date*: 2017-09-12 | |||||||||||
Sponsor Name:CHU de Nantes | |||||||||||||
Full Title: Effects of perioperative administration of dexamethasone on postoperative complications and mortality after non-cardiac major surgery : a randomized, multicentre, double blind, study | |||||||||||||
Medical condition: non-cardiac major surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
